BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8979436)

  • 1. Genetic instability and tumorigenesis: introduction.
    Kastan MB
    Curr Top Microbiol Immunol; 1997; 221():1-4. PubMed ID: 8979436
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk assessments of low-level exposures.
    Abelson PH
    Science; 1994 Sep; 265(5178):1507. PubMed ID: 7832844
    [No Abstract]   [Full Text] [Related]  

  • 3. DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models.
    van Steeg H; de Vries A; van Oostrom CTh ; van Benthem J; Beems RB; van Kreijl CF
    Toxicol Pathol; 2001; 29 Suppl():109-16. PubMed ID: 11695546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemically induced cell proliferation as a criterion in selecting doses for long-term bioassays.
    Swenberg JA; Maronpot RR
    Prog Clin Biol Res; 1991; 369():245-51. PubMed ID: 1946523
    [No Abstract]   [Full Text] [Related]  

  • 5. Beware of a new carcinogenic risk: promotion of promoters.
    Bounias M; Bonaly A
    Toxicol Lett; 1995 Oct; 80(1-3):19-24. PubMed ID: 7482586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of carcinogenesis in risk identification. Introduction.
    IARC Sci Publ; 1992; (116):1-5. PubMed ID: 1428076
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid screening of potential human bladder carcinogens: genotoxicity in meiosis repair deficient Drosophila melanogaster.
    Lamm LM; Reichert DF; Lamm DL
    J Urol; 1989 Nov; 142(5):1356-8. PubMed ID: 2509735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA adducts and other biological markers in risk assessment for environmental carcinogens.
    Perera F; Mayer J; Santella RM; Brenner D; Tsai WY; Brandt-Rauf P; Hemminki K
    Ann Ist Super Sanita; 1991; 27(4):615-20. PubMed ID: 1820734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships in the rat hepatocyte DNA-repair test for 300 chemicals.
    Williams GM; Mori H; McQueen CA
    Mutat Res; 1989 Nov; 221(3):263-86. PubMed ID: 2682231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is current risk assessment of non-genotoxic carcinogens protective?
    Braakhuis HM; Slob W; Olthof ED; Wolterink G; Zwart EP; Gremmer ER; Rorije E; van Benthem J; Woutersen R; van der Laan JW; Luijten M
    Crit Rev Toxicol; 2018 Jul; 48(6):500-511. PubMed ID: 29745287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing and predicting carcinogenicity and mode of action using conventional and toxicogenomics methods.
    Waters MD; Jackson M; Lea I
    Mutat Res; 2010 Dec; 705(3):184-200. PubMed ID: 20399889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinogenesis: basic principles.
    Couch DB
    Drug Chem Toxicol; 1996 Aug; 19(3):133-48. PubMed ID: 8933020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitogenesis is only one factor in carcinogenesis.
    Weinstein IB
    Science; 1991 Jan; 251(4992):387-8. PubMed ID: 1989073
    [No Abstract]   [Full Text] [Related]  

  • 14. DNA damage induced by Salmonella test-negative carcinogens through the formation of oxygen and nitrogen-derived reactive species (review).
    Kawanishi S; Hiraku Y; Inoue S
    Int J Mol Med; 1999 Feb; 3(2):169-74. PubMed ID: 9917525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Working group on mechanisms of carcinogenesis and evaluation of carcinogenic risks.
    Vainio H; Haseltine E; McGregor D; Tomatis L; Wilbourn J
    Cancer Res; 1992 Apr; 52(8):2357-61. PubMed ID: 1559239
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative comparison between in vivo DNA adduct formation from exposure to selected DNA-reactive carcinogens, natural background levels of DNA adduct formation and tumour incidence in rodent bioassays.
    Paini A; Scholz G; Marin-Kuan M; Schilter B; O'Brien J; van Bladeren PJ; Rietjens IM
    Mutagenesis; 2011 Sep; 26(5):605-18. PubMed ID: 21642616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative predictability of carcinogenicity of the covalent binding index of chemicals to DNA: comparison of the in vivo and in vitro assays.
    Taningher M; Saccomanno G; Santi L; Grilli S; Parodi S
    Environ Health Perspect; 1990 Mar; 84():183-92. PubMed ID: 2351121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating human cancer etiology by DNA lesion footprinting and mutagenicity analysis.
    Besaratinia A; Pfeifer GP
    Carcinogenesis; 2006 Aug; 27(8):1526-37. PubMed ID: 16344267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous DNA damage, genome instability, and cancer--when DNA replication escapes control.
    Schär P
    Cell; 2001 Feb; 104(3):329-32. PubMed ID: 11239390
    [No Abstract]   [Full Text] [Related]  

  • 20. Genotoxicity and carcinogenicity testing of pharmaceuticals: correlations between induction of DNA lesions and carcinogenic activity.
    Brambilla G; Mattioli F; Robbiano L; Martelli A
    Mutat Res; 2010; 705(1):20-39. PubMed ID: 20206292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.